Life Sciences

The Life Sciences Industry Practice at Bass, Berry & Sims is a comprehensive team comprised of well-established, experienced attorneys providing the highest level legal service in complementary capabilities, including corporate governance, business transactions, litigation, intellectual property, clinical research, regulatory, products liability, and compliance and government investigations. Our multidisciplinary team of 120 attorneys offers sophisticated counsel and practical solutions to resolve clients’ biggest challenges and seize their greatest opportunities. Our attorneys have represented clients in transformative, precedent-setting and award-winning life sciences matters and bring extensive experience and a deep understanding of the wide variety of commercial, compliance, and regulatory issues that the life sciences industry can face.

We serve as trusted legal and business partners providing comprehensive counsel for clients in the pharmaceutical, biotechnology, digital health and medical device sectors. We also represent the key partners helping to drive the competitive industry forward, including private equity firms, venture capitalists and other strategic investors; clinical research institutions, universities and academic medical centers; technology partners and other vendors; and healthcare providers deploying life sciences innovations around the world. Further, we help guide these same clients through the unique compliance risks facing each sector of the industry.

From companies in the start-up phase to multinational corporations, our attorneys provide strategic guidance on the broad range of matters essential to the research, development and monetization of life sciences innovation. Our team includes several attorneys with prior in-house roles including former general counsels of healthcare companies, specialty pharmacy companies, major institutions and research hospitals focused on advancing the quality of patient care through advancement in life sciences. Our team also includes a number of attorneys that held senior leadership positions for various federal regulatory agencies, including with the U.S. Department of Justice (DOJ), U.S. Department of Health and Human Services (HHS), U.S. Patent Trial and Appeal Board (PTAB), U.S. Department of Justice (DOJ), and the U.S. Securities and Exchange Commission (SEC).

The life sciences industry is poised for dramatic growth in the coming years thanks to technological advances and significant interest from outside investors. As businesses in the life sciences sector look forward to unprecedented opportunity ahead, our deep experience and diverse team offers the benefit of foresight and proactive strategy for any challenges that may arise along the way.

  • Representation of Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and Virginia

    Bass, Berry & Sims represents Mallinckrodt Pharmaceuticals, a global pharmaceutical manufacturer, in numerous cases in courts across Tennessee, Kentucky, and...
    Read More
    Client Type: Public Company
  • Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management.  Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.

    We served as lead legal counsel to POINT Biopharma Inc., a late stage biopharmaceutical company dedicated to bringing the many...
    Read More
    Client Type: Private Company
  • Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder

    We represented Boston Children's Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder. We also assisted Boston...
    Read More
    Client Type: Private Company
  • Representation of ClearPoint Neuro, Inc. in its public offering of 2,127,660 shares with proceeds of $46,800,000.

    We represented ClearPoint Neuro, Inc. in its public offering of 2,127,660 shares with proceeds of $46,800,000. B. Riley Securities acted...
    Read More
    Client Type: Public Company
  • Representation of ClearPoint Neuro, Inc. in its public offering of 2,127,660 shares with proceeds of $46,800,000. B. Riley Securities acted as book-running manager and Lake Street Capital Markets, LLC acted as co-manager for the offering.

     

    We represented ClearPoint Neuro, Inc. in its public offering of 2,127,660 shares with proceeds of $46,800,000. B. Riley Securities acted...
    Read More
    Client Type: Public Company
  • We represented ClearPoint Neuro, Inc. (f/k/a MRI Interventions, Inc.), a global therapy-enabling platform company providing navigation and delivery to the brain, in its $17.5 million strategic investment from PTC Therapeutics, Inc. and Petrichor Healthcare Capital Management, with $10.0 million of notes funded by PTC and $7.5 million of notes funded by Petrichor. With the net proceeds from the sale of the notes to PTC and Petrichor, the ClearPoint Neuro intends to repay in full its existing secured indebtedness, and to fund product commercialization, internal research and development, and general corporate requirements. Additionally, we advised ClearPoint Neuro in the draw of $7.5 million additional proceeds from Petrichor in December 2020. ClearPoint Neuro  intends to use net proceeds to continue funding global product commercialization, external strategic portfolio partnerships, and internal research and development efforts.

    We represented ClearPoint Neuro, Inc. (f/k/a MRI Interventions, Inc.), a global therapy-enabling platform company providing navigation and delivery to the...
    Read More
    Client Type: Private Company
  • Representation of the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible for the operational and strategic management of Chartwell to CarepathRx, a platform company formed by Nautic Partners that offers pharmacy solutions to patients undergoing complicated medication therapies. Nautic will manage the UPMC pharmacy moving forward. Terms of the transaction were not disclosed.

    We represented the University of Pittsburgh Medical Center (UPMC) in the spinoff and sale of the management services organization responsible...
    Read More
    Client Type: Private Company
  • Representation of  Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor of home infusion services. Linden Capital Partners is a Chicago-based private equity firm focused exclusively on the healthcare industry

    We represented Linden Capital Partners, as lead healthcare regulatory counsel, in its investment in Vital Care, Inc., a pharmacy franchisor...
    Read More
    Client Type: Private Company
  • Representation of Lineagen, Inc., a provider of molecular diagnostics services for individuals showing clinical presentations consistent with neurodevelopmental disorders, in its sale to Bionano Genomics, Inc. (Nasdaq: BNGO), a genome analysis company providing tools and services to scientists and clinicians conducting genetic research and patient testing, for $9.6 million

    We represented Lineagen, Inc., a provider of molecular diagnostics services for individuals showing clinical presentations consistent with neurodevelopmental disorders, in...
    Read More
    Client Type: Private Company
  • Served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant provider of infusion pharmacy management services in their sale to CarepathRx a platform company formed by Nautic Partners

    We served as regulatory and deal counsel to BioPlus, a leading national specialty pharmacy, and ProHealth Pharmacy Solutions, a significant...
    Read More
    Client Type: Private Company
Marc E. Ackerman
Counsel
Taylor J. Ashley
Member
Jaime L. Barwig
Member
Michael K. Bassham
Senior Litigation Attorney
Zachary  J. Baumann
Associate
Allison  M. Beattie
Associate
Philip F. Berg
Senior Healthcare Attorney
Matthew H. Berger
Associate
Angela L. Bergman
Associate
Robert L. Brewer
Member
Al Bright, Jr.
Member
Emily A. Burrows
Member
Curtis Capeling
Member
Stefanie P. Carter
Associate
Shu Chen, Ph.D.
Associate
J. Taylor Chenery
Member
Terry L. Clark
Member
E. Steele Clayton, IV
Member
Stefanie Colletier
Associate
Meredith Edwards Collins
Member
Krista Thornton Cooper
Senior Healthcare Attorney
Robert E. Cooper Jr.
Member
David Cox
Member
Matthew M. Curley
Member
Michael G. Dashefsky
Member
Alexandria Wood Davenport
Associate
J. Page Davidson
Member
Katie Day
Member
Margaret Dodson
Associate
Kevin H. Douglas
Member
Kristin C. Dunavant
Counsel
John C. Eason
Member
Richard Eiler
Associate
Jeanne Marie Evans
Associate
Mallory Farrar
Associate
Lindsey Brown Fetzer
Member
D. Lee Flaherty
Associate
Lara A. Flatau
Member
Mary Beth Fortugno
Member
John L. Fuller
Member
Lauren M. Gaffney
Member
Ali Gallagher
Associate
Scott D. Gallisdorfer
Associate
Jeff H. Gibson
Member
Michael C. Gibson
Member
Thomas Gossett
Associate
Tabitha L. Green
Associate
R. Dale Grimes
Member
Anna M. Grizzle
Member
Maleaka N. Guice
Associate
Angela Haddon
Associate
Chelsea L. Harrison
Associate
Elizabeth Harwood
Associate
R. Turner Henderson
Associate
Clint D. Hermes
Counsel
Michael R. Hess
Member
Michael R. Hill
Member
S. Ryan Hoffman
Member
Johnathan D. Holbrook
Associate
Michael J. Holley
Member
Lauren B. Huddleston
Associate
Angela Humphreys
Member
Danielle Dudding Irvine
Associate
Brian Irving
Associate
Brian R. Iverson
Member
J. James Jenkins, Jr.
Member
Stewart W. Kameen
Counsel
Ashleigh Karnell
Associate
John E. Kelly
Member
Kris Kemp
Member
Michael R. Kuffner
Member
Howard H. Lamar III
Member
Richard F. Mattern
Member
Jennifer  E. Michael
Member
Sarah B. Miller
Member
Paige Waldrop Mills
Member
Amy Sanders Morgan
Associate
Whitney Mosey
Associate
Sheaniva H. Murray
Associate
J. Allen Overby
Member
Jacquelyn Papish
Associate
Janice Parmar
Senior Healthcare Attorney
Tatjana Paterno
Member
Frank M. Pellegrino
Member
Dawn Perez-Slavinski
Associate
Brenda Phillips
Counsel
Brianna R. Powell
Associate
Cynthia Y. Reisz
Member
Marc A. Rigsby
Associate
Lisa S. Rivera
Member
Brian D. Roark
Member
Molly K. Ruberg
Associate
Angelique M. Salib
Associate
Taylor M. Sample
Associate
Sehrish Siddiqui
Member
Susan V. Sidwell
Member
Brian L. Sims
Member
Danielle M. Sloane
Member
Katherine Smalley
Associate
David W. Smith
Counsel
Page Minton Smith
Associate
Emily  C. Snyder
Associate
Jonathan D. Stanley
Member
Jacob  B. Stansell
Associate
Jamie Gordon Steakley
Associate
Greg Stevens
Senior Counsel
Craig Stewart
Associate
Julia Tamulis
Member
T. Stephen C. Taylor
Member
Oscar L. Thomas
Counsel
Ryan D. Thomas
Member
Shelley R. Thomas
Member
Nesrin Garan Tift
Member
Quyen Vo
Associate
Janelle D. Waack
Member
Julie C. Walker
Senior Corporate Attorney
Kathryn Hannen Walker
Member
Leigh Walton
Member
Elizabeth S. Warren
Member
Hannah E. Webber
Associate
Nikki Wethington
Associate
Shannon Wiley
Member
Caitlin Wilkinson
Associate
Price W. Wilson
Member
Abby Yi
Associate
Jessalyn H. Zeigler
Member

Publications

Upcoming Events

Past Events

Media Mentions & Firm News